Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
| ▸ | HTR3A | P46098 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 2/20 | 0.41 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.40 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.40 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.40 |
| ▸ | USP28 | Q96RU2 | 1/20 | 0.39 |
| ▸ | USP25 | Q9UHP3 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25330905 | 0.82 | CHRNB2 (0.49) | SLC18A3SIGMAR1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL14282659 | 0.76 | SLC18A3 (0.68) | SLC18A3SIGMAR1HTR2C | |
| SCHEMBL3045406 | 0.74 | HTR2C (0.51) | SLC18A3SIGMAR1HTR2C | |
| SCHEMBL31412742 | 0.73 | HTR3A (0.61) | HTR3ACHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL27723048 | 0.73 | HTR3A (0.61) | HTR3ACHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL2079179 | 0.72 | CHRNB2 (0.45) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL3348156 | 0.71 | TRPA1 (0.44) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL9159120 | 0.71 | CHRNB2 (0.43) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL9159113 | 0.71 | CHRNB2 (0.43) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL6159027 | 0.71 | HTR2C (0.54) | SLC18A3SIGMAR1HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2473048-A1 | PYRANYL ARYL METHYL BENZOQUINAZOLINONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | Merck Sharp & Dohme Corp. (US) | 2012-07-11 | — | — | EP | disclosed |